30^th European Nephrology Conference

Diabetic Kidney Disease & Metabolic Disorders

This track focuses on diabetic kidney disease and metabolic conditions that significantly impact renal health worldwide. Sessions will explore the pathophysiology of diabetic nephropathy, early detection strategies, risk stratification, and factors influencing disease progression. Emphasis will be placed on timely intervention to prevent complications and slow the decline of kidney function. Key discussions will highlight emerging and established therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists, along with their clinical benefits and real-world applications. The track will also address obesity-related kidney disease, insulin resistance, metabolic syndrome, and their interconnections with cardiovascular risk. Lifestyle modification, optimal glycemic control, blood pressure management, and patient education will be central themes. Multidisciplinary care models involving nephrologists, endocrinologists, dietitians, and primary care providers will be emphasized to improve outcomes. This track supports integrated, evidence-based strategies for managing metabolic kidney disease.